Cooperative role of tumour necrosis factor‐α, interleukin‐1β and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice
暂无分享,去创建一个
F. Lopes | D. Souza | T. Silva | D. Sachs | F. Amaral | F. Coelho | M. M. Teixeira | V. Pinho | V. V. Costa | A. Teixeira | M. Teixeira | Vivian V Costa
[1] I. McInnes,et al. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ production , 2009, Proceedings of the National Academy of Sciences.
[2] M. Teixeira,et al. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. , 2008, Arthritis and rheumatism.
[3] M. Teixeira,et al. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. , 2008, Arthritis and rheumatism.
[4] F. Cunha,et al. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception , 2008, Journal of leukocyte biology.
[5] F. Cunha,et al. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats , 2008, British journal of pharmacology.
[6] J A Peters,et al. Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.
[7] P. Kubes,et al. Modulating leukocyte recruitment in inflammation. , 2007, The Journal of allergy and clinical immunology.
[8] M. Martins,et al. Neutrophil infiltration is implicated in the sustained thermal hyperalgesic response evoked by allergen provocation in actively sensitized rats , 2006, Pain.
[9] F. Cunha,et al. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? , 2006, Pharmacology & therapeutics.
[10] F. Cunha,et al. Hypernociception elicited by tibio-tarsal joint flexion in mice: A novel experimental arthritis model for pharmacological screening , 2006, Pharmacology Biochemistry and Behavior.
[11] F. Cunha,et al. Nociceptive Effect of Subcutaneously Injected Interleukin-12 Is Mediated by Endothelin (ET) Acting on ETB Receptors in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[12] I. McInnes,et al. A fork in the pathway to inflammation and arthritis , 2005, Nature Medicine.
[13] G. Firestein. Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[14] C. Cook,et al. Nociceptive Sensitivity and Opioid Antinociception and Antihyperalgesia in Freund's Adjuvant-Induced Arthritic Male and Female Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[15] F. Cunha,et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] Andrea Messori,et al. New drugs for rheumatoid arthritis [6] (multiple letters) , 2004 .
[17] F. Colotta,et al. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury , 2004, British journal of pharmacology.
[18] F. Liew,et al. Interleukin-18 Induces Mechanical Hypernociception in Rats via Endothelin Acting on ETB Receptors in a Morphine-Sensitive Manner , 2004, Journal of Pharmacology and Experimental Therapeutics.
[19] F. Cunha,et al. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Donaldson,et al. Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice , 2003, Journal of Neuroscience Methods.
[21] A. Kohara,et al. Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics , 2003, Journal of Pharmacology and Experimental Therapeutics.
[22] G. Firestein. Evolving concepts of rheumatoid arthritis , 2003, Nature.
[23] C. Parada,et al. Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Mauro M Teixeira,et al. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. , 2002, The American journal of pathology.
[25] M. Teixeira,et al. Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. , 2002, European journal of pharmacology.
[26] G. Cassali,et al. Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injury , 2001, British journal of pharmacology.
[27] Paul M. Allen,et al. Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis1 , 2001, The Journal of Immunology.
[28] A. Talvani,et al. Eosinophil recruitment into sites of delayed‐type hypersensitivity reactions in mice , 2001, Journal of leukocyte biology.
[29] S. Poole,et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat , 2000, British journal of pharmacology.
[30] D. C. Cara,et al. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. , 2000, European journal of pharmacology.
[31] H. Genant,et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. , 2000, Arthritis and rheumatism.
[32] M. Millan,et al. The induction of pain: an integrative review , 1999, Progress in Neurobiology.
[33] E. Tindall,et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.
[34] P. Kubes,et al. Tumor necrosis factor-alpha induces leukocyte recruitment by different mechanisms in vivo and in vitro. , 1997, Journal of immunology.
[35] M. Teixeira,et al. The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo , 1997, British journal of pharmacology.
[36] P. Kubes,et al. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. , 1995, The Journal of clinical investigation.
[37] M. Fournié-Zaluski,et al. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation , 1994, Pain.
[38] J. Besson,et al. A limited arthritic model for chronic pain studies in the rat , 1992, Pain.
[39] G. Weissmann,et al. The role of the neutrophil in rheumatoid arthritis. , 1991, Clinical orthopaedics and related research.
[40] E. Goetzl,et al. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. , 1984, Science.
[41] S. Ferreira. Prostaglandins, aspirin-like drugs and analgesia. , 1972, Nature: New biology.
[42] H. Okamoto. Tumor necrosis factor inhibitors for rheumatoid arthritis. , 2006, The New England journal of medicine.
[43] F. Cunha,et al. An electronic pressure-meter nociception paw test for mice. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[44] Michael H SchiV. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis , 2000 .
[45] M. Shimaoka,et al. Fucoidin, a potent inhibitor of leukocyte rolling, prevents neutrophil influx into phorbol-ester-induced inflammatory sites in rabbit lungs. , 1996, American journal of respiratory and critical care medicine.
[46] K. Ley,et al. Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery. , 1993, Blood.